Prevision Medicine AG is a oncology company that provides cancer therapy, tests living cancer cells, and deliver clinical insights.
Prevision Medicine has raised $5.4M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Prevision Medicine's investors include GoHub Ventures, ACE Ventures, SICTIC, Future of Health Grant.
Prevision Medicine is headquartered in Zürich, Switzerland.
Prevision Medicine AG is a oncology company that provides cancer therapy, tests living cancer cells, and deliver clinical insights.
Prevision Medicine is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prevision Medicine — Funding & Investors." VCBacked, September 24, 2026, https://www.vcbacked.co/company/prevision-medicine. Accessed October 1, 2026.
VCBacked. (2026). Prevision Medicine — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/prevision-medicine
{{cite web |title=Prevision Medicine — Funding & Investors |url=https://www.vcbacked.co/company/prevision-medicine |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated